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Abstract 
Background: The American Physical Therapy Association identified the need for training in 
evidence based practice (EBP) and set forth guidelines for doctor of physical therapy (DPT) 
curricula to educate practitioners who are efficient and critical users of best evidence. Since 
DPT programs are teaching EBP, educators need an assessment tool to evaluate the competence 
of students. The Modified Fresno Test (MFT) of EBP was validated for physical therapists and 
the test-retest reliability and minimal detectable change (MDC) has been found for first year 
DPT students. 
Objective: The purpose is to determine the test-retest reliability and MDC of the MFT in first, 
second, and third year DPT students. A secondary purpose is to compare the mean total score of 
the MFT among the three student groups. 
Design: Test-retest design 
Methods: Using a simple random sample, we recruited 21 University of New England (UNE) 
DPT students from each of the three classes. The participants completed the MFT twice, 
separated by 14 days, in a classroom on UNE's campus. 
Results: Students in the third year class completed the validated 13-item MFT and due to a 
photocopying error, students in the first and second year class completed an 11-item MFT. The 
first year students had the lowest 11-item MFT mean score (68.5 points) which was significantly 
lower than the second and third year student groups (85.7 and 88.2 points, respectively). First 
year students had the lowest ICC and highest MDC (0.23 and 40.4 points). Third year students 
had the highest ICC and lowest MDC (0.73 and 23.0 points). 
Limitations: We were unable to analyze scores from the 13-item MFT for all three student 
groups. The rater did not receive training in the MFT scoring rubric. Participation in the study 
was not a requirement. 
Conclusions: The 13 and 11-item MFT has good test-retest reliability for UNE's third year DPT 
student group. The 11-item MFT has poor to moderate test-retest reliability for first and second 
year DPT students. 
1 Introduction: 
2 According to Sackett et al!, evidence-based medicine is the thorough and judicious use of the 
3 best current evidence in decision making about the care of individual patients. Although 
4 beginning in the field of medicine, using evidence in clinical decision making is evolving to 
5 include physical therapy and other health care professions. Since this notion is incorporated into 
6 practice by all professions, evidence-based medicine is now referred to as evidence-based 
7 practice (EBP). Professional organizations, such as the American Physical Therapy Association 
8 (APTA), have identified the need for increased training in evidence based practice for their 
9 healthcare professions and at every level of education.2 The APTA has set forth guidelines for 
10 doctor of physical therapy (DPT) curricula to educate practitioners who are efficient and critical 
11 users of current evidence and who understand how to combine that evidence with their own 
12 clinical knowledge and with patients' preferences. The goal is that current practitioners will be 
13 lifelong learners who possess the knowledge and skill-set required to remain current with 
14 physical therapy's evolving knowledge base.3 
15 
16 One method to introduce and teach EBP is by using a five-step framework, referred to as the five 
17 A's: ask, acquire, appraise, apply, and assess. The practitioner first asks a focused clinical 
18 question which is followed by acquiring the best available current evidence. The evidence 
19 should then be critically appraised and applied to the patient population. The final step requires 
20 assessment of the outcomes. The Section on Research of APTA recommends DPT education 
21 programs use this framework to educate physical therapists how to discover, evaluate, and 
22 integrate trustworthy evidence into their professional practice.3 
23 Now that DPT programs are teaching evidence-based practice, educators need an assessment tool 
24 supported by evidence to evaluate the competence of students.2 The original Fresno Test (FT) 
25 was established to assess EBP knowledge and skill of medical students. Ramos4 developed the 
26 FT for family practice residents at University of California, San Francisco's Fresno family 
27 practice residency program. The FT used opened ended questions, some that required 
28 calculations, to allow for higher order thinking. Although Ramos4 found the FT was found to be 
29 simple, reliable, and valid for assessment of knowledge and skill, it does not evaluate how the 
30 practitioner applies or assesses the evidence.5 Additionally, the FT is specific to medical 
31 students. 
32 
33 Since EBP is utilized by other healthcare professions, the Adapted Fresno Test (AFT) was 
34 designed to assess knowledge of EBP in occupational therapists (OT) after a weekend continuing 
35 education course. McKluskey6 adapted the FT to include scenarios specific to OT and found 
36 that the AFT was a valid assessment tool. After the FT was successfully adapted for OT, Tilson5 
37 developed the Modified Fresno Test (MFT) for use with physical therapists. The FT was 
38 expanded to encompass PT specific scenarios. She validated it by testing EBP-novice PT 
39 students, EBP-trained PT students, and EBP-expert PT faculty. Miller, Cummings and 
40 Tomlinson7 found that the MFT can be scored reliably by trained raters using the rubric made by 
41 Tilson.5 She reported an intra-rater reliability (ICC 2,1) of 0.85 (95% CI 0.60-0.97), an inter-
42 rater reliability of 0.83 (95% CI 0.74-0.96), and a test-retest reliability of 0.46 (95% CI 0.16 -
43 0.69). She found a minimal detectable change (MDC) of 25.6 points, a value which is used to 
44 assess true change in individual performance.7 
45 The MDC and test-retest reliability have been determined for 1st year DPT students. However, 
46 these values may differ with different levels of EBP knowledge. Therefore, the primary purpose 
47 of this study is to determine the test-retest reliability and minimal detectable change of the 
48 Modified Fresno Test in 1st, 2nd, and 3rd year DPT students. A secondary purpose is to 
49 compare mean MFT scores among the three student groups. 
50 
51 Methods: 
52 Design Overview: 
53 The study used exploratory research to investigate the psychometric properties of test- retest 
54 reliability and minimal detectable change. 
55 
56 Setting and Participants: 
57 Using a simple random sample, we recruited 21 UNE DPT students each from the first, second 
58 and third year classes. Each of the three classes was represented by the recruited student group. 
59 According to Bonett8, a sample size of 21 subjects will be adequate to detect an intraclass 
60 correlation coefficient of 0.90 at alpha of 0.05 with a confidence interval 0.20. 
61 
62 To recruit subjects, we gave a group presentation to each of the three classes describing details of 
63 our study. Using a random number generator, we randomly selected 21 students from each class. 
64 The selected students were sent an email informing them that they have been selected. We 
65 asked the students to reply within 24 hours with their agreement to participate. If they did not 
66 wish to participate or did not respond in 24 hours, we selected another student at random until we 
67 had 21 participants. Inclusion criteria included enrollment in the UNE DPT program. There 
68 were no exclusion criteria except the investigators of this study (LG and EP). 
69 
70 The study took place at the UNE campus in Portland, Maine. UNE is a private school that 
71 enrolls approximately 60 students per DPT class to their eight semester long program (Appendix 
72 2. Curriculum). Students take PTH 514 Scientific Inquiry 1 in the spring semester of their first 
73 year and PTH 602 Scientific Inquiry 2 during the fall semester of their second year. These two 
74 courses include an introduction to and application of EBP, respectively (Appendix 3. Course 
75 Descriptions). At the time of test administrations, first year students had not taken either 
76 Scientific Inquiry class; second year students had completed PTH 514 Scientific Inquiry 1; and 
77 third year students had completed both Scientific Inquiry courses. Although these two classes 
78 directly pertain to EBP, EBP is threaded throughout all three years via assignments in various 
79 classes. 
80 
81 MFT Protocol: 
82 The MFT contains 13 questions: eight are short answer response, two require mathematical 
83 calculations, and three are fill in the blank response (Appendix 4. Modified Fresno Test). The 
84 test takers are introduced to a definition of EBP and are then given two clinical scenarios of three 
85 to four sentences each and choose one scenario to answer the 13 items on the test. In general, 
86 each response is graded as excellent, strong, limited, minimal, or not evident. Points are 
87 assigned to each question based on their pertinence.5 The total score ranges from 0 - 224, with 
88 higher scores suggesting higher EBP knowledge. 
89 The MFT was administered in writing twice to each class of students. We recruited and 
90 administered the two tests to second year students near the beginning of the summer semester in 
91 June 2014. We recruited and administered the tests to the first and third year students at the 
92 beginning of the fall semester 2014 (Appendix 2. Curriculum). Time between the two test 
93 administrations of the MFT was 14 days as Miller, Cummings and Tomlinson7 used in their 
94 study. Participants were allowed up to 60 minutes to complete the test in a designated room with 
95 supervision. No external resources were permitted except for a calculator. Note paper was 
96 provided. Each participant was assigned a separate identification number for each test in order to 
97 mask the participants identity and version of the MFT (test one and test two) to prevent grading 
98 bias. After both tests were completed they were scored on paper by Michael Fillyaw PT, MS, an 
99 EBP expert, professor of PTH 514 Scientific Inquiry 1 and our research advisor for this study, 
100 using Tilson's scoring rubric5 (Appendix 4. Modified Fresno Test). 
101 
102 Statistical Analysis: 
103 To achieve the primary purpose of the study, test-retest reliability was calculated separately for 
104 MFT total score for each student group using intraclass correlation coefficient [ICC (2,1)].9 
105 Standard error of measure (SEM) was calculated separately for MFT total score for each of the 
106 three student groups using: SEM = SDinitiaiv 1 — ICC where SD^ is the standard deviation of 
107 the scores for test one.10 The SEM was then used to calculate the MDC for each student group 
108 using: MDC95 = Critical Z-Score95 * SEM * V2 where the critical z-score for 95% level of 
109 confidence is 1.96.10 
110 
111 To achieve the secondary purpose, we used an analysis of variance to test for the significance of 
112 the difference in mean total scores among the three groups. We also tested for the significance of 
113 the difference in mean total scores for test one and test two within the three student groups by a 
114 paired t-test. A level of significance of p-value <0.05 was used for both analyses. SYSTAT 13 
115 was utilized for all of our statistical analyses. 
116 
117 Results: 
118 A total of 53 students, 20 from the third year class, 18 from the second year class and 15 from 
119 class the first year class, who participated in both test administrations, were analyzed for the 
120 primary and secondary purposes of our study (Figure 1). 
121 
122 Third year students received the complete 13-item MFT as intended. Due to a photocopying 
123 error, questions 10 and 11 were not included in the test packets received by first and second year 
124 student groups, therefore, first and second year students did not complete the 13-item MFT as 
125 designed. We will refer to the MFT without questions 10 and 11 as the "11 -item MFT". 
126 
127 To achieve our secondary purpose, the mean and standard deviation for total score for the 13-
128 item MFT were calculated only for the third year students. The mean and standard deviation for 
129 total score of the 11-item MFT were calculated for each of the three classes (Table 1). The 
130 ANOVA showed significant differences in mean total scores for the 11-item MFT among three 
131 student groups (Table 2). The third year student group had the highest mean score and the first 
132 year student group had the lowest. A Bonferroni post hoc analysis was done to determine which 
133 pairs were different among the three classes. This analysis revealed that the second and third 
134 year student groups were different from the first year student group (Table 2 and Figure 2). 
135 
136 To achieve our primary purpose, the ICC and MDC were calculated for the total score of the 13-
137 item MFT for the third year students and for the 11-item MFT for each student group (Figures 3 
138 and 4). The third year student group had the highest ICC values of 0.77 and 0.73 for their 13-
139 item and 11-item MFT, respectively (Figure 3). The third year student group also had the lowest 
140 MDC values of 21.61 and 23.04 points for the 13-item and 11 -item MFT, respectively (Figure 
141 4). The first year students had the lowest ICC value of 0.23 and the highest MDC value of 40.4 
142 points (Figure 3 and 4). 
143 
144 The second year students were recruited in May of 2014 and completed both test administrations 
145 in June of 2014. The first and third year students were recruited in August of 2014. Test one 
146 was completed at the end of September of 2014 and test two was completed in the beginning of 
147 October of 2014. No adverse events took place during the study. 
148 
149 Discussion: 
150 We suspected that mean MFT scores would increase with increased exposure to EBP. The 
151 results of the Bonferonni post hoc analysis supported our hypothesis. The analysis found a 
152 significantly lower mean total score on the 11-item MFT in the first year students compared to 
153 both the second and third year students. The difference in mean total scores of the 11-item MFT 
154 between the second and third year classes was not statistically significant, however the third year 
155 class scored higher than the second year class, as expected. This difference may not be 
156 significant because third year students may have given less effort than second year students. The 
157 third year students may have felt obligated to participate in order to assist fellow classmates 
158 (investigators EP and LG). Lack of motivation was noted in this student group, especially during 
159 the second test administration. Students in the first and second year classes were supervised by a 
160 faculty or staff member, whereas students in the third year class were supervised by peers. 
161 
162 We suspected there would be a difference in ICC and MDC values among each group of 
163 students. We found that higher ICC values were associated with a higher total MFT score. None 
164 of our ICC values indicate high test-retest reliability (>0.90), however the ICC value for the third 
165 year class (0.73) allows us to consider the 11-item MFT as having good reliability for this 
166 student group.9 The first and second year classes revealed ICC values (0.63 and 0.23) indicative 
167 of poor to moderate test-retest reliability.9 
168 
169 The ICC is determined both by the extent of agreement in participant scores as well as variability 
170 of their scores. ICC will be highest when scores agree from test one to test two and there is a 
171 heterogeneous group of participants.9 Unlike the second and third year classes, at the time of test 
172 administrations the first year students had no exposure to EBP through UNE's DPT curriculum. 
173 Any experience the first year students had would be unique to each participant, resulting in more 
174 variability in their scores than second and third year classes. Because of this, we initially 
175 suspected that the first year students would have a high test-retest reliability. However, our first 
176 year class was the most homogenous group with respect to MFT total score. The students' mean 
177 total scores were very similar to one another, and revealed minimal knowledge of EBP, having 
178 the lowest mean score out of all three student groups. The third year student group was the only 
179 group to have a significant difference in mean total scores on the 11 -item MFT from test one to 
180 test two (Figure 5), but their MFT total scores were the most variable. The large amount of 
181 variability among students was sufficient to overcome the significant difference in mean total 
182 scores and resulted in the highest ICC value. The variability in scores of the third year class is 
7 
183 understandable because although the students had been exposed to EBP through the curriculum, 
184 each student had established a unique and variable amount of EBP knowledge. 
185 
186 The option to choose one of two scenarios for the MFT may have influenced the test-retest 
187 reliability through decreasing the agreement of scores. There was no prohibition against students 
188 choosing one scenario on test one and choosing the other scenario on test two. Although both 
189 scenarios were considered valid for the physical therapy population5, if a participant did not 
190 choose the same scenario on both test administrations, he/she could have essentially taken two 
191 different tests. 
192 
193 The open-ended responses required on the MFT may have contributed to lower test-retest 
194 reliability compared to another more objective form of testing. Students could have easily and 
195 unknowingly altered their responses from test one to test two. The open-ended format could 
196 have also impacted scores due to the rater. Scoring the open-ended responses relied heavily on 
197 the rater's interpretation of answers, which may not have been consistent within or among 
198 subjects. 
199 
200 The MDC values also differed between classes. Students in the third year class had the highest 
201 test-retest reliability and the lowest MDC value (23.04 points). The MDC value for the second 
202 year class (27.15 points) was similar to that of the third years and the ICC values were also 
203 similar. The first year class had the lowest ICC value (0.23) and the highest MDC value (40.3 8 
204 points). 
205 
206 To our knowledge, this is the first study to examine the test-retest reliability of the validated 13-
207 item MFT and our 11-item MFT. Miller, Cummings and Tomlinson7 looked at the test-retest 
8 
208 reliability and total mean score of the original 14-item MFT for first year DPT students and 
209 found an ICC of 0.46 with a MDC of 18.2 points and mean total score of 107 points from a 
210 possible total score of 232 points. In her validity study, Tilson5 found that question nine in the 
211 14-item MFT exhibited unsatisfactory psychometric properties and recommended not including 
212 it in the test. The third-year students was the only group in our study to take the validated 13-
213 item MFT (total possible points 224). The mean score of the 13-item MFT for the third year 
214 student group was 88.2 with a MDC of 21.61 and ICC of 0.77. 
215 
216 This is the first study of the MFT to utilize students who have not received formal EBP training 
217 through a DPT program. Miller, Cummings and Tomlinson's7 novice group received a short 
218 EBP course consisting of seven to ten hours of EBP content. This was similar to Tilson's study 
219 whose novice group received seven hours of EBP training which included an introduction to 
220 EBP, writing searchable questions, searching, and appraising literature. The participants from 
221 our first year class, those with the least amount of EBP exposure, did not receive an introductory 
222 course to EBP as a part of this study. Our findings agree with Tilson's5, that novice evidence 
223 based practitioners had the lowest MFT scores and most experienced evidence based 
224 practitioners had the highest MFT scores. 
225 
226 Tilson5 weighted questions one through seven higher (worth 24 points each) than other questions 
227 (ranging from 4 to 16 points) since they were considered to have greater importance. Our third 
228 year students scored higher on these questions than our first and second students. Additionally 
229 the third year students scored low on questions 10 and 11 which asked about relative risk, 
230 likelihood ratio, number needed to treat, positive predictive value, risk reduction, sensitivity, or 
231 P-value. This low score may be due to little emphasis UNE's DPT program places on these 
9 
232 mathematical calculations. The inclusion of questions 10 and 11 resulted in a mean score of 5.7 
233 points higher for the 13-item MFT compared to the 11-item MFT when there was a possibility to 
234 score an additional 28 points. Knowing the scores for each individual question allows faculty at 
235 UNE to identify areas of strength and weakness in the EBP curriculum and to make changes as 
236 desired. 
237 
238 Limitations: 
239 Due to a photocopying error the statistical analysis was limited to comparing the 11-item MFT 
240 for the classes of 2016 and 2017. This did not allow us to analyze the ICC, MDC, or total mean 
241 score for the 13-item MFT for the classes of 2016 and 2017. 
242 
243 The rater of the tests did not receive formal training in the scoring rubric of the MFT as was 
244 provided for the raters in other studies57(Appendix 4. Modified Fresno Test). The MFT test-
245 retest reliability also depends on consistency of raters scoring the test for accuracy and there may 
246 have been variance within our rater's interpretation of the student's answers. 
247 
248 Participation in the study was not required and, therefore, participants may not have taken it 
249 seriously resulting in lower and varied scores from test one and test two. 
250 
251 Conclusions: 
252 The 13-item and 11 -item MFT can be considered as having good test-retest reliability for a third 
253 year DPT student group with similar EBP exposure as taught in UNE's DPT program. The 11-
254 item MFT exhibited poor to moderate test-retest reliability for first and second-year DPT 
255 students. The high MDC value in the first year student group, which was associated with their 
256 low test-retest reliability, highlights the need for a first year DPT student to score 40.4 points 
10 
257 higher or lower to demonstrate meaningful change. Future research is needed to assess the test-
258 retest reliability of the validated 13 -item MFT for students in the first and second year class of a 
259 DPT program. 
260 
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Figure 1 MFT Participation Flow Chart 21 students from each DPT class were recruited. After both test administrations, 
we were able to analyze the MFT scores for 53 students. 
Table 1 Differences between Test 1 and Test 2 for each class 
MFT Question {Possible Points) 
1. Form a clinical question (24) 
2. Sources of information (24) 
3. Study design (24) 
4. Search strategy (24) 
5. Relevance of study (24) 
6. Validity of study (24) 
7. Magnitude, significance of study (24) 
8. Questions for patient/famiiy (8) 
10. Sensitivity, PPV, LR (12) 
11. RR, NNT, p-value(16) 
12. Confidence Interval (4) 
13. Best study design - diagnosis (4) 
14. Best study design - prognosis (4) 
MFT total 13-item (224) 
MFT total 11-item (196) 
First Year 
T1 
Mean 
11.1 
15.5 
8.6 
8.2 
7.5 
7 
3.9 
3.4 
NT 
NT 
0.0 
0.3 
1 
NT 
71.8 
SD 
5.1 
6.6 
6.9 
2.8 
5.9 
6.2 
2.8 
2.3 
NT 
NT 
0.0 
1 
1.7 
NT 
16.6 
T2 
Mean 
12.8 
13.1 
6.9 
8.7 
10.8 
4.4 
3.6 
2.2 
NT 
NT 
0.0 
0.6 
0.6 
NT 
65.3 
SD 
4.8 
4.9 
5.8 
3.6 
5.2 
4.4 
3.2 
1 
NT 
NT 
0.0 
1.4 
1.4 
NT 
15.1 
P-
value 
>0.05 
<0.05 
>0.05 
>0.05 
>0.05 
<0.05 
>0.05 
<0.05 
NT 
NT 
>0.05 
>0.05 
>0.05 
NT 
>0.05 
Second Year 
T1 
Mean 
18.8 
8 
13.2 
18.3 
12.4 
8.2 
5.9 
2.6 
NT 
NT 
0.9 
0.2 
0.4 
NT 
88.9 
SD 
3.8 
5.4 
4.7 
5.2 
5.8 
6.8 
5.6 
1.5 
NT 
NT 
1.7 
0.9 
1.3 
NT 
16.1 
T2 
Mean 
18.1 
6.6 
13.5 
16.6 
9.9 
5.9 
7.5 
3.1 
NT 
NT 
0.9 
0.2 
0.2 
NT 
82.5 
SD 
4.4 
5.1 
4.7 
6.1 
4.5 
5.3 
4.4 
1.6 
NT 
NT 
1.7 
0.9 
0.9 
NT 
12.4 
P-
value 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
NT 
NT 
>0.05 
>0.05 
>0.05 
NT 
>0.05 
Third Year 
T1 
Mean 
20.2 
9.6 
16.7 
16.3 
11.8 
4 
7.6 
3 
1.4 
3.5 
1 
0.4 
2 
97.3 
92.5 
T2 
SD 
3.7 
4.5 
5.4 
4.7 
4.9 
4.2 
4.8 
2 
2.3 
2.1 
1.8 
1.2 
2.1 
16.3 
16.0 
Mean 
18.2 
7.4 
12 
15.6 
12 
3.9 
7 
2.4 
1.3 
5.4 
2.4 
1.6 
1.4 
90.55 
83.9 
SD 
4.7 
4.9 
5 
5.1 
7.2 
5.2 
4.9 
1 
1.8 
2.6 
2 
2 
2 
21.4 
20.2 
P-
value 
>0.05 
>0.05 
<0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
<0.05 
<0.05 
<0.05 
>0.05 
>0.05 
<0.05 
MFT= Modified Fresno Test 
T1= MFT test administration 1 
T2= MFT test administration 2 
SD= standard deviation 
NT= not tested 
PPV=positive predictive value, LR= likelihood ratio 
RR= risk reduction, NNT= number needed to treat 
MFT total 13-item= sum of questions 1-8,10-14 
MFT total 11-item= sum of questions 1-8,12-14 
Table 2. Comparison of each question and tota 
MFT Question (Possible Points) 
1. Form a clinical question (24) 
2. Sources of information (24) 
3. Study design (24L 
4. Search strategy (24) 
5. Relevance of study (24) 
6. Validity of study (24) 
7. Magnitude, significance of study (24) 
8. Questions for patient/family (8) 
10. Sensitivity, PPV, LR (12) 
11. RR, NNT, p-value (16) 
12. Confidence Interval (4) 
13. Best study design - diagnosis (4) 
14. Best study design - prognosis (4) 
MFTtotaM3-item(224) 
MFTtotal11-item(196) 
1 s t year 
Mean 
12.8 
15.3 
8.1 
8.9 
9.6 
6.0 
3.8 
2.9 
NT 
NT 
0.0 
0.4 
0.8 
NT 
68.5 
SD 
4.4 
5.0 
6.5 
3.0 
5.9 
5.8 
3.0 
1.9 
NT 
NT 
0.0 
1.2 
1.6 
NT 
15.9 
score among 
2nd year 
Mean 
18.4 
7.3 
13.3 
17.4 
11.2 
7.1 
6.7 
2.8 
NT 
NT 
0.9 
0.2 
0.3 
NT 
85.7 
SD 
4.1 
5.2 
4.7 
5.7 
5.3 
6.1 
5.0 
1.5 
NT 
NT 
1.7 
0.9 
1.1 
NT 
14.5 
classes 
3rd year 
Mean 
19.2 
8.5 
14.3 
15.9 
11.9 
4.0 
7.3 
2.7 
1.3 
4.5 
1.7 
1.0 
1.7 
93.9 
88.2 
SD 
4.3 
4.8 
5.6 
4.8 
6.1 
4.7 
4.8 
1.6 
2.0 
2.5 
2.0 
1.8 
2.0 
19.1 
18.5 
P-value 
0.000 
0.000 
0.000 
0.000 
0.274 
0.049 
0.004 
0.845 
NT 
NT 
0.000 
0.039 
0.002 
NT 
0.000 
Bonferroni 
Test 
2015?* 2017; 
2016*2017 
20155*2017; 
2016*2017 
2015*2017; 
2016*2017 
2015*2017; 
20165*2017 
No 
differences 
2015*2016 
2015*2017; 
2016*2017 
No 
differences 
NT 
NT 
2015*2017 
2015*2016 
2015*2016 
NT 
2015*2017; 
2016*2017 
MFT= Modified Fresno Test, MFT total 13-item= sum of questions 1-8, 10-14, MFT total 11-item= sum of 
questions 1-8, 12-14 
SD= standard deviation 
PPV=positive predictive value, LR= likelihood ratio 
RR= risk reduction, NNT=number needed to treat 
NT= not tested 
r 
^ 
v. >-
:'-r/-"M» «/> 
O 
CO 
r-i 
O 
CD 
O 
•=fr 
vH 
O O 
o 
O 
CO o CD 
O 
"3- o CM 
ajoos l^ioi ueajAi 
CD 
CD 
CD 
-Q 
CO 
CD 
o u 
CO 
E 
CD 
•^ 
rH 
t - l 
"CD 
•M O 
•M 
c 
ro 
CD 
E 
.E 
CD 
u 
c 
CD 
i _ 
CD 
4 — 
^ 
T3 
+-» C 
03 
O 
cV 
' c 
.SP 
'co 
03 
CD 
4-» 
CO 
u 
XJ 
p 
CO 
•M CD 
JS 
u 
ro 
CQ 
CO 
CD 
a-
O 
u (/) 
"ra 
o 
H 
ro 
CD 
2 
fM 
CD 
3 
.SP 
in 
CO* 
•M c CD 
X5 
3 
• M 
CO 
l_ 
ro 
CD 
> 
-a 
c rsl 
o3 
4-> 
V ) 
X> 
c 
03 
" D 
CO 
o3 
-M 
l / l 
rH 
1 -
0.9 
0.8 
0.7 
0.6 -
01 
I 0.5 
u 
u 
0.4 
0.3 
0.2 -
0.23 
1st year { l l - i tem MFT) 
• l i t I 
ill) r 
2nd year { l l - i tem MFT) 
0.73 
Sieiawi 
mm-
mmm 
ffit$MlW^tj$tP£' 
3rd year { l l - i tem MFT) 
0.77 
• • • • 
3rd year (13-item MFT) 
Figure 3 Test-Retest Reliability Increasing ICC values are associated with increasing exposure to EBP. The 13-item 
MFT given only to 3rd year students had the highest ICC value. 
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Figure 4 Minimal Detectable Change The 1s t year class must score 40.4 points higher on subsequent 11-item MFT to 
demonstrate a true change in scores which is n 
lower exposure to EBP and a lower MFT score. 
much higher than the 2nd and 3rd year classes. A higher MDC is associated with 
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Figure 5 Mean Total Score 11-item MFT mean total scores Test 1, Test 2 :1 s t years 71.8, 65.3; 2nd years 88.9, 82.5; 3rd 
years 97.3, 90.6. 13-item MFT mean total scores Test 1, Test 2: 92.5, 88.3. The only statistically significant difference in 
mean total scores between test 1 and test 2 was on the 11-item MFT for third year students. Total possible points for 
the 11-item MFT is 196 points. Total possible points for the 13-item MFT is 224 points. 
Appendix 1. Budget and Budget Justification 
RESEARCH PROJECT BUDGET 
A. All personnel for whom money is 
requested 
Erin Pike 
Lisa Gerhardt 
Annual 
Salary 
$65,000 
$65,000 
Period from: May 2014 
Through: December 2014 
Benefits 
$16,250 
$16,250 
% time on project 
12.5% 
12.5% 
Subtotal A = 
B. Equipment 
Subtotal B = 
C. Consumable Supplies 
Paper 
Pencils 
Subtotal C = 
D. Dissemination 
Student CSM registration 
Airfare 
Hotel 
Meals and Incidental expenses 
Subtotal D = 
Requested funds 
$10,156.25 
$10,156.25 
$20,312.50 
Requested funds 
$0.00 
Requested funds 
$34.02 
$13.99 
$48.01 
Requested funds 
$280.00 
$610.50 
$376.00 
$355,00 
$1,621.50 
Appendix 2 . U N E D P T Curriculum 
C U R R I C U L U M B Y S E M E S T E R 
Y E A R 1 YEAR 2 YEAR 3 
AY2 - Summer 11 AY3 - Summer 8-10 
BIO 504-Neuroscience 
PTH 516 - Pathology & Med Management: 
Cardiovascular 
PTH 522 - PT Management of Patients - Disorders: 
Cardiovascular and Pulmonary Systems 
PTH 525 - Practice Management 
PTH 524 - Clinical Education Seminar 
PTH 607-Clinical Practicum 2 8 
PTH 608 - Case Report 1 (Distance Education 2* 
Course) 
AY1 Fall 17 AY2-Fall 10 AY3 - Fall 13 
BIO 502 - Gross Anatomy 6 
PTH 501 - Foundations of PT Practice 5 
PTH 502-Kinesiology 5 
PTH 507 - Introduction to Clinical Medicine 1 
PTH 601 - Clinical Practicum 1 
PTH 602 - Scientific Inquiry 2 (Distance Education 
Course) 
PTH 700 - Administration 
PTH 701 - Pathology & Med Management: 
Disorders of the Integumentary System 
PTH 703 - PT Management of Patients: Disorders 
Of the Integumentary System 
PTH 704 - Disease Prevention & Health Promotion 
PTH 705 - Research Project 
PTH 708 - Case Report 2 
PTH 710 - Complex Case Management 
3 
2* 
2* 
1 
AY1 - Spring 18 
PTH 503 - Normal Development 2 
PTH 506 - Psychosocial Aspects of Disability and 1 
Illness 
PTH 508 - Pathology & Med Management: 2 
Musculoskeletal System 
PTH 510- PT Management of Patients - Disorder: 11 
Musculoskeletal System 
PTH 514-Scientific Inquiry 1 2 
AY2 - Spring 
PTH 603 - Pathology & Med Management: 
Disorders of the Neuromuscular System 
PTH 604 - PT Management of Children: 
Disorders of the Neuromuscular System 
PTH 605 - PT Management of Adults: 
Disorders of the Neuromuscular System 
PTH 606 - Research Proposal 
14-16 
6 
2* 
AY3 - Spring 10 
PTH 706 - Public Policy and Physical Therapy 2 
PTH 707 - Clinical Practicum 3 8 
Appendix 3. Course Descriptions 
PTH 514 Scientinc Inquiry 1: An introduction to the methods used to conduct clinical research in physical therapy. Topics include: 
accessing the professional literature using electronic databases, evidence-based practice, and evaluating the literature of physical 
therapy through examination of the research process including sampling, experimental design and control, ethics of clinical research, 
properties of measurements, and statistical inference. 
PTH 602 Scientific Inquiry 2: The physical therapy student applies the principles of evidence-based practice to clinical problems. This 
includes: 1) asking patient-centered questions, 2) identifying, searching, and critically appraising published sources of evidence, and 
3) integrating the evidence along with clinical expertise, and the patient's circumstances and preferences into clinical decisions. This 
course is offered in distance-learning format concurrent with PTH 601: Clinical Practicum I. Students are required to have a computer 
with Microsoft Word and Internet access. 
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Appendix 4. Modified Fresno Test and scoring rubric 
Instructions: 
Evidence Based Practice (EBP) involves knowledge and skills related to identifying and evaluating evidence to inform practice. This 
tool, the modified Fresno Test is designed to assess your EBP skills. 
There are 8 short answer questions, 2 questions that require a series of mathematical calculations, and 3 fill-m-the-blank questions. A 
calculator and note paper have been provided for you. Additional resources (internet sites, books, etc) are not permitted. 
Please complete the entire test in one sitting and allow yourself up to 60 minutes to complete the test. 
Answer questions 1-4 and 8 based on the following clinical scenarios: 
Scenario 1: You have just evaluated Mary, a secretary who recently experienced a work related low-back injury moving 10,25 lbs. 
file boxes 3 days ago. Her radiographs are negative and her only symptom is resolving 2/10 pain across the low back with forward 
bending and prolonged sitting. She has been off of work for 2 days and is eager to return but is also anxious about re-injury. You are 
considering a stabilization exercise program but wonder if manual therapy should be included in the patient's physical therapy 
program. 
Scenario #2: Marvin is a 10 year-old boy with hemiparesis secondary to stroke associated with an Arterial-Venous Malformation. He 
presents to outpatient therapy and his parents express particular concern about Marvin's arm and leg weakness. You are considering 
implementing an intensive task-specific strengthening program but a colleague warns that such a program is likely to increase the 
patient's moderate flexor tone and spasticity and suggests low intensity stretching and a passive positioning program. 
QUESTION #1: Choose one of the above clinical scenarios. Write a focused clinical question for that scenario that will help you 
organize a search of the clinical literature. 
a: 
Population 
b: 
Intervention 
c: 
Comparison 
d: 
Outcome 
Excellent 
6: Multiple relevant descriptors; 
e.g., "work-related injury," 
"female" or "acute," or" or 
"low-back pain"; e.g., "boy 
with hemiparesis" specific age 
group, gender, diagnosis, motor 
presentation 
Strong 
4: One appropriate 
descriptor as above 
examples; e.g. "women" 
or "worker" or "low-back 
pain"; e.g. "hemiparesis" 
"boy" "10 year old" 
"post-stroke" . 
6: Includes specific intervention 1 
of interest; (intervention could I ^ ^ ^ ^ ^ ^ ^ H ^ ^ H H R 
be a diagnostic technique); I ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H I 
•manual therapy ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H B M H M I 
• specific individual ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ K ^ B I 
components of manual therapy 1 
• combination of exercise and 1 
manual therapy; H 
•task-specific strengthening 
6: Identifies specific alternative 
of interest; e.g. "no manual I 
therapy"; "low intensity 1 
stretching" ^ ^ B t M ^ ^ ^ B H H r c 
6: Outcome that is objective and 
meaningful to patient or patient 
case (if question is diagnostic, 
should relate to diagnosis trying 
to detect); e.g.return to work, 
pain reduction, injury 
prevention; e.g. selective motor 
control or functional use of 
paretic extremities, walking 
velocity 
4: Non-specific outcome: 
• recovery 
• spasticity 
• tone 
• strength 
Limited Minimal Not evident 
2: A single general descriptor l ^ H 
unlikely to contribute to search; e.g. 
"patient" ^ H 
2: Mentions intervention but ^ ^ | 
unlikely to contribute to search; e.g. 
"methods" "options" "treatments" | ^ K 
2: Mentions comparison but | ^ H 
unlikely to contribute to search; e.g. 
"alternate methods" 1 
2: Reference to outcome, but so ^Hf l 
general as to be unlikely to ^ ^ f l 
contribute to search ^ H 
• effects ^ ^ f l 
• change the outcome ^^M 
• effective ^ ^ H 
• improvement I 
• success ^ ^ | 
• change the outcome j ^ H 
1 0: None of 
1 the above 
1 present 
1 0: None of 
• the above 
I present 
1 0: None of 
1 the above 
1 present 
1 0: None of 
1 the above 
• present 
6 
QUESTION #2: Where might you find answers to this and other similar clinical questions? Name as many possible sources of 
information as you can — not just the ones you think are 'good' sources. Describe the advantages and disadvantages of each type of 
information source you have listed. 
a: 
Variety of 
Sources 
b: 
Convenience 
Excellent 
6: At least four types of sources listed. Types include: 
• electronic databases of original literature 
[Medline(PubMed/Ovid), CINAHL] 
• discipline specific databases (Hooked on Evidence, PEDro) 
• journals (JAMA, NEJM, incl. access through library) 
• text book (Merck, Harrisons, monographs) 
• Systematic Reviews (Cochrane) 
• EBM publications or databases of pre-appraised information (Best 
Evidence, InfoRetriever, DynaMed, EBM, ACPJC, EBP, Clinical 
Evidence) 
• Medical website (MDConsult, PraxisMD, SumSearch) 
• General internet search (google, yahoo) 
• Clinical Guidelines (Guideline Clearinghouse, 
• Professional Organization (AAFP, La Leche League, NEH 
website) 
• People (colleague, consultant, attending, librarian) 
6: Discussion includes at least 2 specific issues related to 
convenience, or mentions the same issue while discussing two 
different sources. Issues may include: 
• Cost (e.g. "free," "subscription only") 
• Speed (e.g. "fast," "takes time") 
•. Ease of search (e.g. "must know how to narrow search," "easy to 
navigate") 
• Ease of use (e.g. "concise" and 'TSINTs already calculated") 
• Availability (e.g. "readily available online") 
Strong 
4: Three types 
of sources 
listed. 
4: Includes 1 
specific 
issue/explanati 
on related to 
convenience 
Limited Min Not 
evident 
2: Two types of 1 0:No 
sources listed. 1 variety. 
1 Only one 
1 source 
B listed, or 
1 all 
1 sources of 
1 same 
1 type. 
2: Mentions 1 0: No 
convenience 1 mention 
involved in | of 
using one or 1 convenien 
more source, but I I ce 
without H ^ B 
explanation I 
I 
"convenient" or B 
"easy" or ^ ^ ^ H 
"difficult" ^^M 
.-»>., 
#2 Continued 
c: 
Clinical 
Relevance 
d: 
Validity 
Excellent 
6: Discussion includes at least 2 specific issues related to relevance, or 
mentions the same issue while discussing two different sources. Issues 
may include: 
• Clinically relevant outcomes 
• Written for clinical application (e.g. "pertinent" "info on adverse 
effects" or "has patient information sheets") 
• Appropriate specialty focus (e.g. "directed at PTs") 
• Irrformation applicable to patient in question (e.g. "can go over details 
of this particular patient" or "most of studies are from Europe") 
• Includes specific interventions in question 
• Specificity (overview vs. targeted) (e.g. "can get basic information" 
or "more specialized") 
• Comprehensiveness of source (likelihood of finding an answer in that 
source) (e.g. "she can find anything" or "contains usable references" 
or "not likely to have answer to this question") 
6::Discussion includes at least 2 specific issues related to validity, or 
mentions the same issue while discussing two different sources. Issues 
may include: 
• Certainty of validity (e.g. quality is uncertain" or "has not been 
screened" or "needs to be critically appraised") 
• Evidence Based approach (e.g. "evidence based" or "Grade 1 
Evidence" or "no references provided") 
• Expert bias (e.g. "usually just someone's opinion") 
• Systematic approach 
• Peer review 
• Ability to verify 
• Standard of care (e.g. "accepted in medical community") 
• Enough information provided to critique validity (e.g. "abstract 
only" or "not available full-text") 
• 1 Up-to-date/outdated (e.g. "most recent research") 
• Reliability - in the context of the degree of trust that can be places 
on the resource 
Strong 
4: Includes 1 
specific 
issue/explana 
tion related 
to relevance 
4: Includes 1 
specific 
issue/explana 
tioh related 
to validity 
Limited 
2: Mentions 
relevance of using 
one or more source, 
but without 
explanation 
e.g. "relevant" 
2: Mentions i 
validity of using 
one or more source, 
but without 
explanation 
e.g. "good" "junk" 
Not 
evident 
0:No 
mention 
of 
relevance 
0:No 
mention 
of validity 
QUESTION #3: What type of study (study design) would best answer your clinical question outlined in Q l and why? 
a: 
Study Design 
b: 
Justification 
Excellent 
12: Names one of the best 
sources: 
• Randomized Controlled 
Trial 
• Randomized Trial 
• Systematic Review; 
• Meta-Analysis 
• Randomized, Double 
Blinded Clinical Trial 
12: Includes well-reasoned 
justification that reflects 
understanding of the 
importance of 
randomization and/or 
blinding. Explicitly 
connects randomization to 
reduction of confounding 
and/or blinding to observer 
or measurement bias. 
e.g. "An RCT will attempt 
to avoid any bias which 
would influence the 
outcome of the study 
through randomization" OR 
"best suited for therapy 
questions because it 
reduces bias and controls 
for confounding factors." 
Strong 
9: Describes but does not 
call by name one of the best 
sources as above 
• comparing two groups, 
one gets treatment, other 
gets placeo 
• double blind study 
9: Justification is present, 
and touches on issues 
related to randomization 
and/or blindrng, but less 
clearly articulated 
e.g. "groups should be 
similar" or "try to eliminate 
confounding factors" or 
"avoid selection bias" or "to 
be objective" or "to 
eliminate bias" 
Limited 
6: Describes or names a 
less desirable study 
design: 
« Cohort study 
• Prospective clinical 
trial 
• meta-analysis of such 
studies 
• Longitudinal or 
prospective 
6: Justification is present, 
and raises legitimate 
issues unrelated to 
randomization or 
blinding, such as cost 
effectiveness, ethical 
concerns, recall bias. 
May mention 
randomization or blinding 
but without explanation. 
(e.g. "best in a random 
and blind setting") 
e.g. "chart reviews 
provide lots of data 
without much cost" 
Minimal 
3: Describes or names a 
poor study design to 
answer a treatment 
question: 
• case control, cross 
sectional study, case 
report, "retrospective" 
• Or describes a study 
with insufficient detail 
to identify a design: 
e.g. a comparative 
study 
3: Attempted 
justification, but 
arguments are non-
specific and do not 
demonstrate 
understanding of the 
relationship between the 
design and various 
threats to validity 
May mention 
randomization or 
blinding but without 
explanation, (e.g. "best 
in a random and blind 
setting") 
e.g. "to ensure quality" 
or "to reduce potential 
conflicts" or "to 
compare" 
Not 
evident 
0: None 
of above 
present 
0: None 
of above 
present 
QUESTION #4: If you were to search Medline, CINAHL or any other database for original research to answer your 
clinical question related to the scenario you selected for Question 1, describe the search strategy you might use. Be as 
specific as you can about the search terms and search fields you would use. Explain your rationale for taking this approach. 
Describe how you might limit your search if necessary and explain your reasoning. 
a: 
Search Terms 
b: 
Tags/Strategy 
c: 
Delimiters 
Excellent 
8: 3 or more terms that reflect patient, 
intervention, comparison, and outcome 
(PICO) being considered 
8: Description of search strategy reflects 
understanding that articles in database are 
indexed by more than one field. 
Discusses one or more field/index/tag by 
name (MeSH, Title Word, Publication Title, 
language, Keyword, author, Journal title, use 
of boolean operators, etc.) 
AND provides plausible rationale for search 
strategy using 1 or more of these indices 
e.g. "keyword is less specific than MESH" 
8: Describes more than one approach to 
limiting search (e.g., "limit to human" or 
"adult" or "English"), names a specific 
publication type, or describes of Clinical 
Queries in PubMed, or the use of Boolean 
operators or search combinations or includes 
terms related to an optimal study design (e.g. 
randomized) or suggests use of subheadings 
* NOTE: If the subject includes the name of 
the index when describing a delimiter (e.g. 
"check language as English") then we give 
credit for a tag as well as a method of 
delimiting. 
Strong 
6: 2 terms from PICO 
6: Names 1 or more field or 
index category but does not 
provide plausible defense of 
search strategy based on this 
knowledge 
e.g. "I would do a keyword 
search.. .followed by..." 
"I would use terms ... in this 
way" 
6: Describes only 1 common 
method of limiting search 
e.g. describes ways to narrow 
search using keywords but no 
other strategies listed 
Limited M Not evident 
3: 1 term from PICO B 0: Not present 
3: weak description J 0: No evident 
of strategy, no name 1 understanding 
given to tags, or 1 1 that articles 
overtly misguided I "tagged" by 
strategy | different fields 
1 or indices 
e.g. "I would use H H 
terms .. ." [no B 
description of | 
strategy] H N 
3: provides weak I I ^ : No valid 
explanation or • H I techniques for 
description of use of M i limiting a 
limiters/narrowing 1 search listed 
search MM 
10 
. •:-" 
•:•••'• AA#,;^ 
severity as my patient?" or 
• "did selection or inappropriate inclusion 
criteria result in a study population that 
differs from mine by race, age, etc" 
criteria?" or 
• "selection bias" or 
• "setting" or 
• "where study was 
conducted" 
NOTE: RESPONSES TO QUESTIONS 5. 6, AND 7, CAN BE APPLIED TO ANY PORTION OF THE GRADING RUBRIC FOR 
THOSE ITEMS 
12 
QUESTION US: When you find a report of original research on this question or any others, what characteristics of the study will you 
consider to determine if it is relevant? Include examples. Questions 6 and 7 will ask you how to determine if the study is valid, and 
how important the findings are. For this question, please focus on how to determine if it is really relevant to your practice. 
a: 
The 
Question 
b: 
Description 
of Subjects 
Excellent 
12: Well-reasoned and thoughtful discussion 
of the relevance of the independent and 
dependent variables used in the study 
including examples/specific reasons. 
May discuss (well-reasoned and thoughtful): 
• the feasibility of the test or intervention 
• "the test might work but if my practice can't 
afford to buy the machine it doesn't matter" 
• the patient or disease-oriented nature of the 
outcome 
• "did they measure children's ability to use 
improved function in play activities?" 
• the congruence between the operational 
definition and the research question e.g. 
"whether their method of measuring the 
outcome is a realistic representation of the 
outcome we care about" 
12: Includes both: 
A clear expression of the importance of the 
link between the study subjects and target 
population. 
AND 
At least one example of a relevant disease or 
demographic characteristic 
• e.g. "were the patients similar to mine in 
terms of age and race?" or 
• "was it a hospital or clinic sample like my 
patients?" or 
• "did patients have same level of disease 
Strong 
9: Less thoughtful discussion 
of the relevance of the 
independent and dependent 
variables used in the study. 
May include specific concepts 
or examples without clear 
rationale. 
May refer to same items listed in 
'excellent' but without 
demonstrating depth of. 
understanding. 
9: Includes one but not both': 
A clear expression of the 
importance of the link between 
the study subjects and target 
population 
OR 
At least one example of a 
relevant disease or demographic 
characteristic ; 
e.g. "is the patient like mine?" or 
"education level of population" 
Limited 
5: Response implies 
consideration of how well 
the study addresses the 
question at hand, but offers 
little discussion about why 
this may be important 
• e.g. "what are the 
variables?"; 
• "does it answer my 
question?"; 
"• "the outcome measure"; 
• "the purpose of the study"; 
• "will it impact my 
practice?"; 
• "length of follow-up" 
5: Response implies 
consideration of the study 
subjects, but offers no 
discussion of the connection 
between study subjects and 
target population or 
specific characteristics of 
the sample 
• e.g. "is it an appropriate 
sample?" or 
• "what was the response or 
participation rate?" or 
• "what were the exclusion 
Not evident 
0:No 
discussion 
ofthe 
research 
question 
and 
variables 
used to 
answer it. 
0:No 
discussion 
ofthe 
characterist 
ics ofthe 
research 
subjects. 
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QUESTION #6: When you find a report of original research related to your clinical question or any others, what 
characteristics of the study will you consider to determine if its findings are valid? (You've already addressed relevance, and 
question 7 will ask how to determine the importance of the findings. For this question, please focus on the validity of the 
study.) 
a: Internal 
Validity 
Excellent 
24: Lists or describes at least 5 issues important to internal 
validity, such as: 
• Appropriateness of study design 
• Adequacy of blinding 
• Allocation concealment 
• Randomization of group assignment 
• Invalid or biased measurement ("followed own 
protocol?") 
• Importance of comparison or control group 
• Intentioh to treat analysis 
> Consideration of appropriate covariates ("were other 
relevant factors considered?") 
• Conclusions consistent with evidence ("do the results 
make sense?") 
• Importance of follow-up of all study participants 
• Appropriate statistical analysis 
• Sample size / Power 
• Sponsorship 
• When study was conducted 
• Confirmation with other studies 
• Valid outcome measures 
Strong 
18: Identifies 3-4 
specific issues as 
above. 
Limited 
10: Identifies 
2 specific 
issues as 
above. 
Minimal 
5: Mentions 
internal 
validity or 
lists one 
specific 
concept from 
examples 
above. 
Not 
evident 
0: None 
of the 
above 
present 
NOTE: RESPONSES TO QUESTIONS 5, 6. AND 7, CAN BE APPLIED TO ANY PORTION OF THE GRADING RUBRIC 
FOR THOSE ITEMS 
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QUESTION #7: When you find a report of orig inal research which relates to your 
characteristics of the findings will you consider to determine their magnitude and 
a: Magnitude 
b: 
Statistical 
Significance 
Excellent 
12: Response must clearly discuss 
both: 
• clinical significance ("what is the 
clinical significance?" or "how 
large a difference was found?", 
does change exceed MCH)) 
AND 
• example(s) of effect size 
measurements (e.g., specificity, 
sensitivity, likelihood ratio of a 
test, number needed to treat, 
relative risk, absolute risk 
reduction, mean difference for 
continuous outcomes, positive or 
negative predictive value) 
12: Well-reasoned and thoughtful 
discussion of the indices of statistical 
significance, including at least 2 
specific examples of important 
related concepts such as: 
• p-values 
• confidence intervals 
• power 
• precision of estimates 
« Type 1 or Type 2 error 
Strong 
9: Response discusses one but not 
both: 
• clmical significance ("what is the 
clinical significance?" or "how 
large a difference was found?") 
OR 
• example(s) of effect size 
measurements (e.g., specificity, 
sensitivity, likelihood ratio of a 
test, number needed to treat, 
relative risk, absolute risk 
reduction, mean difference for 
continuous outcomes, positive or 
negative predictive value) 
9: Lists more than one concept (as 
above) With insufficient or absent 
discussion (e.g. "p-value and 
confidence intervals") 
OR 
Lists and discusses only one concept 
(e.g. "p-value less than <.05") 
clmical question or any others, wha t 
significance (clinical and statistical)? 
Limited 
5: Response only suggests 
Minim 
al Not evident 
0: None of 
consideration of clinical I the above 
significance or size of I I present 
effect. ^ ^ ^ H i 
• e.g. "does it matter?" ^ ^ ^ ^ | 
"will it impact my . 1 
practice" or ^ ^ ^ H 
• e.g. mentions "Minimal 
Clinically Important 1 
Difference" but does 1 
not explain how this I 
value would be used to fl^E| 
determine clinical ^ ^ ^ ^ 1 
significance) 
5: Mentions need to 0: None of 
assess statistical 1 the above 
significance or names 1 present 
only one concept from fl|^|E 
above without further | | 
discussion (e.g. "p- fl^^^l 
values", "statistically l ^ ^ ^ H 
significant") i ^ ^ ^ H 
NOTE: RESPONSES T O QUESTIONS 5.-6VAND7. CAN BE APPLIED T O ANY PORTION OE T H E G R 
FOR THOSE ITEMS 
ADING RUBRIC 
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QUESTION #8: For the clinical scenario that you chose, list up to two questions that you would ask the patient/family to gain a 
better unders anding of his or her personal preferences and/or circumstances regarding your clinical question. 
Excellent Strong Limited 
a: Question 1 8: Question is likely to elicit important 
information about patient preferences, 
values, circumstances, expectations, 
and/or motivations that are will directly 
impact clinical care. 
b: Question 2 8: same as above but elicits different 
information than the first question 
(otherwise 0) 
4: Question is 
general but 
addresses issues 
relevant to 
understanding the 
patient's 
perspective 
4: same as above 
but elicits different 
information than 
the first question 
(otherwise 0) 
Minimal 
2: Question is general and does not 
address issues specific to the 
patient's perspectives 
e.g. Standard question from 
subjective evaluation not specific to 
patient perspectives 
e.g. Yes/No or factual questions that 
are unlikely to elicit details about 
patient perspective 
2: same as above but elicits different 
information than the first question 
(otherwise 0) 
Not evident 
0: No question or 
not an actual 
question 
• "past medical 
history" or 
• "preferences" 
0: No question or 
not an actual 
question 
Item #9 was dropped from the final version of the modified FT due to poor psychometric performance. 
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QUESTION #10: 
A study of the diagnostic accuracy of exercise treadmill testing (ETT) in diagnosing of coronary artery disease (CAD) included 96 
women with suspected CAD, 29 of whom were subsequently determined to have CAD (>50% stenosis in one or more coronary 
vessels). Of those with CAD, 9 had an abnormal ETT. Of the 67 patients determined not to have CAD, 32 had an abnormal ETT. 
* Alternative text using natural frequency values: 
A study of the diagnostic accuracy of exercise tteadmill testing (ETT) in diagnosing of coronary artery disease (CAD) included 120 
women with suspected CAD, 30 of whom were subsequently determined to have CAD (>50% stenosis in one or more coronary vessels). 
Of those with CAD, 10 had an abnormal ETT. Of the 90 patients determined not to have CAD, 30 had an abnormal ETT. 
Excellent 
a: 
Based on these results, the sensitivity of ETT 
for CAD is... 
4: 0.31; 31%; 9/29 
*4: 0.33; 33%; 10/30 
b: Based on these results, the positive 
predictive value of ETT for CAD is... 
4: 0.22; 22%; 9/41 
*4: 0.25; 25%; 10/40 
c: Based on these results, the likelihood ratio 
positive for an abnormal ETT for CAD is... 
4: 0.65; 31/47 
*4: 1.0; 0.333/1-0.666 
Strong 
3: Within 5%: 26-36% 
3: Within 5%: 17-27% 
3: Within 5%: 0.60-0.70 
Rounding is acceptable (e.g. 21.9 to 22 is acceptable) 
Not evident 
0: No answer 
or wrong 
answer 
0: No answer 
or wrong 
answer 
0: No answer 
or wrong 
answer 
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QUESTION #11: A recent randomized trial of pregnant women with incontinence found that after pelvic floor training 20% 
had incontinence compared to 32% in a control group at 3 mos after delivery. Alpha level for the study was set at the 0.05 
significance level. 
* Alternative text using natural frequency values: 
A recent randomized trial of pregnant women with incontinence found that after pelvic floor ftaining 20% had incontinence compared 
to 30% in a control group at 3 mos after delivery. Alpha level for the study was set at the 0.05 significance level. 
a: The absolute risk reduction for recurrent 
events is... 
b: The relative risk reduction for recurrent 
events is... 
c: The number needed to treat (NNT) to 
prevent one recurrent event is... 
d: The p-value indicating statistically 
significant difference between the groups 
would be... 
4: 0.12; 12% 
*4: 0.10; 10% 
4: 0.38; 38%; 12/32 
*4: 0.33; 33%; 10/30 
4: 9; 1/0.12 
*4:10; 1/0.10 
4: <0.05 
3: within 2%: 10-14% 
3: within 2%: 36-40% 
3: within 1:8-10 
3: 0.05 
0: No answer 
or wrong 
answer 
0: No answer 
or wrong 
answer 
0: No answer 
or wrong 
answer 
0: No answer 
or wrong 
answer 
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QUESTION #12: The same study described in question 11 revealed a relative risk of incontinence of 0.61 for the 
women receiving pelvic floor training. This suggests that pelvic floor training treatment reduces risk for incontinence. 
We wonder if this difference is statistically significant, so we look at the confidence interval. Give an example of a 
confidence interval that would support the conclusion that the rate of incontinence was indeed (statistically] 
different for these two treatment groups. 
* Alternative text using natural frequency values: 
The same study described in question 11 revealed a relative risk of incontinence of 0.66 for the women receiving pelvic floor 
training. This suggests that pelvic floor training treatment reduces risk for incontinence. We wonder if this difference is 
statistically significant, so we look at the confidence interval. Give an example of a confidence interval that would support the 
conclusion that the rate of incontinence was indeed (statistically] different for these two treatment groups. 
a 
Excellent 
4: Indication that any CI that does not 
include 1 would indicate statistical 
significance 
Strong | Limited [Minimal Not evident 
• 0: Other 
QUESTION #13: Which study design is best for a study about diagnosis? 
4: Cohort Study; Cross Sectional Study; 
Comparison with gold standard; 
systematic review 
0: Other 
QUESTION #14: Which study design is best for a study about prognosis? 
4: Cohort; prospective; longitudinal; 
systematic review 
0: Other 
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